Roxindole

This classification denotes a serotonin agonist and dopamine agonist with the molecular formula C23H26N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 43227SMS0O, chemically known as 3-(4-(3,6-dihydro-4-phenyl-1(2h)-pyridinyl)butyl)-1h-indol-5-ol but generally known as roxindole, which bears US NIH Compound Identifier 219050. European Medicines Agency schedules Roxindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10399MIG. The term ROXINDOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). ROXINDOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule roxindole under HS 29333999 and SITC 51574. As of Q4 2014, ROXINDOLE remains the US FDA Preferred Term for this commodity. Roxindole bears US NLM identifiers UMLS ID C0286106 and NCI Concept Code C90625. SMILES: Oc1cc2c(CCCCN3CCC(=CC3)c3ccccc3)c[nH]c2cc1.